KALA BIO, INC. Increase (Decrease) in Restricted Cash
KALA BIO, INC. (KALA) reported Increase (Decrease) in Restricted Cash of $12.21 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2019-03-12
- KALA BIO, INC. increase (decrease) in restricted cash for the quarter ending 2018-12-31 was $10.03M, a 1002700.00% increase year-over-year.
- KALA BIO, INC. increase (decrease) in restricted cash for the quarter ending 2018-09-30 was $0.00.
- KALA BIO, INC. increase (decrease) in restricted cash for the quarter ending 2018-06-30 was $2.00K, a 92.00% decline year-over-year.
- KALA BIO, INC. increase (decrease) in restricted cash for the quarter ending 2018-03-31 was $2.18M, a 1896.33% increase year-over-year.
- KALA BIO, INC. increase (decrease) in restricted cash for fiscal 2018 was $12.21M, a 9008.96% increase from fiscal 2017.
- KALA BIO, INC. increase (decrease) in restricted cash for fiscal 2017 was $134.00K, a 22.94% increase from fiscal 2016.
- KALA BIO, INC. increase (decrease) in restricted cash for fiscal 2016 was $109.00K, a 0.00% change from fiscal 2015.
- KALA BIO, INC. increase (decrease) in restricted cash for fiscal 2015 was $109.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 6 month as first filed | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 9 month as first filed | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $10.03M derived: sum of 2 quarters · filed 2019-03-12 | $10.03M derived: sum of 3 quarters · filed 2019-03-12 | $12.21M 10-K · filed 2019-03-12 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.00K derived: sum of 2 quarters · filed 2018-11-08 | $2.18M 10-Q · filed 2018-11-08 | $2.18M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2018-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.18M 10-Q · filed 2018-08-09 | $2.18M derived: sum of 3 quarters · filed 2019-03-12 | $2.18M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2018-03-31 | $2.18M 10-Q · filed 2018-05-10 | $2.18M derived: sum of 2 quarters · filed 2019-03-12 | $2.18M derived: sum of 3 quarters · filed 2019-03-12 | $2.20M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $25.00K derived: sum of 3 quarters · filed 2019-03-12 | $134.00K 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $24.00K derived: sum of 2 quarters · filed 2018-11-08 | $133.00K 10-Q · filed 2018-11-08 | $25.00K 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $134.00K 10-Q · filed 2018-08-09 | $25.00K 10-Q · filed 2017-08-31 | |||
| 2017-03-31 | $109.00K 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | $109.00K 10-K · filed 2018-04-02 | |||||
| 2015-12-31 | $109.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |